Showing 1421-1430 of 6664 results for "".
UV Safety Goes Viral, Salon Exposures Exposed
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-uv-safety-goes-viral-salon-exposures-exposed/18439/The Skin Checker viral video from La Roche Posay coincides with the launch of La Roche Posay's new Anthelios Dermo-KIDS Sunscreen SPF 60. The company has also reported data showing the benefits of its wearable My UV Patch sensor and associated kid-friendly mobile app. Neutrogena's MimicMommy MOVEmenAdvocating for the Specialty and Patient Safety
https://practicaldermatology.com/topics/practice-management/advocating-for-the-specialty-and-patient-safety/18702/George J. Hruza, MD, Past President of the American Society for Dermatologic Surgery (ASDS), sat down with DermTube Journal Club Host Nancy J. Samolitis, MD to discuss the importance of getting involved with organizations like the ASDS and the American Academy of Dermatology Association to advocateTime to Revamp Your Practice Website
https://practicaldermatology.com/topics/practice-management/time-to-revamp-your-practice-website/18706/Your website is your digital storefront. To optimize the benefit of your site, you must review it frequently to be sure you are making the most of technological advancements and search rankings. Keep an eye toward an outstanding user experience (UX). Learn what you need to know to keep your websiteGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoAnonymous Reviews on Google+ and How They Impact Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/anonymous-reviews-on-google-and-how-they-impact-your-dermatology-practice/18827/Online reviews are a fact of modern medical practice. Many physicians fret over negative reviews, but what about positive reviews? Learn how reviews influence your search rankings, how patients assess reviews, and how you can create a Google+ page that allows for anonymous reviews of your practice.Neotensil®: A Novel, Noninvasive Solution That Reduces the Appearance of Under-Eye Bags
https://practicaldermatology.com/topics/practice-management/neotensil-a-novel-noninvasive-solution-that-reduces-the-appearance-of-under-eye-bags/19058/Neotensil is the only noninvasive solution clinically proven to reduce the appearance of under-eye bags within an hour, with benefits that last up to 16 hours. Doris Day, MD, discusses the benefits of Neotensil, as well as patient selection, staff training and how to incorporate this unique and effeThe Importance of Planning
https://practicaldermatology.com/topics/practice-management/the-importance-of-planning/19082/Failing to plan is planning to fail, say Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions. They tell aesthetic practices how to lay the foundation for success in minimally invasive procedures.New Hope for the Hopeless
https://practicaldermatology.com/issues/august-2025/new-hope-jak-inhibitors-alopecia/36693/Dr. Elizabeth (Lisa) Swanson, a dermatologist and associate medical editor of Practical Dermatology, looks at the critical role of case reports in developing new therapeutic options for patients.The Importance of Diversity in Clinical Trials
https://practicaldermatology.com/issues/april-2025/the-importance-of-diversity-in-clinical-trials/35606/The disproportionate representation of certain segments of the population in clinical trials is no secret, and research has shown that psoriasis studies are the least racially diverse of all dermatology studies in the US.Addressing Equity Gaps in Psoriasis Research
https://practicaldermatology.com/series/c-suite-chats/addressing-equity-gaps-in-psoriasis-research/33151/LaShell Robinson, Head, Global Feasibility and Trial Equity for Takeda, discusses the disproportionate underrepresentation of certain racial and ethnic groups in clinical trials, especially for psoriasis, and how Takeda is seeking to close those gaps in recent Phase 3 trials.